Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India · Delayed Price · Currency is INR 1,645.00
-245.10 (-12.97%)
Oct 22, 2026, 3:29 PM IST
Tatva Chintan Pharma Chem Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 6,499 | 5,059 | 3,827 | 3,935 | 4,236 | 4,336 |
Revenue Growth | 49.69% | 32.18% | -2.74% | -7.11% | -2.31% | 44.38% |
Gross Profit Gross Profit Growth | 3,464 | 2,707 | 1,767 | 2,105 | 1,910 | 2,321 |
Operating Income Operating Income Growth | 892.1 | 591.06 | 66.82 | 437.83 | 584.69 | 1,005 |
Net Income Net Income Growth | 629.18 | 420.54 | 57.13 | 303.54 | 454.87 | 958.74 |
Earnings Per Share EPS Growth | 26.90 | 17.98 | 2.44 | 13.26 | 20.52 | 44.59 |
EPS Growth | 254.70% | 636.80% | -81.60% | -35.38% | -53.98% | 71.39% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Overseas Overseas Growth | 3,818 | 2,355 | 2,769 | 3,042 | 3,405 |
India India Growth | 1,188 | 1,444 | 1,136 | 1,167 | 908.27 |
Total Total Growth | 5,006 | 3,799 | 3,905 | 4,209 | 4,313 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 152.05 | 61.04 | 117.01 | 456.68 | 412.15 | 638.19 |
Total Debt Total Debt Growth | 1,700 | 1,204 | 363.88 | 142.71 | 1,703 | 1,199 |
Net Cash (Debt) Net Cash Growth | -1,548 | -1,143 | -246.87 | 313.97 | -1,290 | -561.19 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -66.18 | -48.85 | -10.55 | 13.72 | -58.22 | -26.10 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 144.32 | 314.89 | 247.74 | 980.44 | 277.83 | 202.3 |
Capital Expenditures CapEx Growth | -886.2 | -1,138 | -762.72 | -1,285 | -2,031 | -891.57 |
Free Cash Flow Free Cash Flow Growth | -741.88 | -822.85 | -514.98 | -304.71 | -1,753 | -689.27 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 53.31% | 53.52% | 46.18% | 53.50% | 45.08% | 53.53% |
Operating Margin | 13.73% | 11.68% | 1.75% | 11.13% | 13.80% | 23.17% |
Pretax Margin | 13.01% | 11.32% | 1.98% | 11.08% | 10.52% | 24.01% |
Profit Margin | 9.68% | 8.31% | 1.49% | 7.71% | 10.74% | 22.11% |
FCF Margin | -11.42% | -16.27% | -13.46% | -7.74% | -41.39% | -15.90% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 1.000 | 2.000 | 2.000 | 2.000 |
Dividend Per Share Growth | 100.00% | 100.00% | -50.00% | 0% | 0% | -60.00% |
Dividend Yield | 0.12% | 0.19% | 0.15% | 0.18% | 0.12% | 0.09% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 61.15 | 58.54 | 277.26 | 83.12 | 81.33 | 53.37 |
Forward PE | 51.04 | 40.11 | 41.06 | 29.94 | 36.07 | 42.29 |
PS Ratio | 6.80 | 4.87 | 4.14 | 6.41 | 8.73 | 11.80 |